CPT2 rs74315295: Understanding Stress-Induced Myopathy Risks
The rs74315295 variant is a specific genetic change located within the CPT2 gene. It is associated with stress-induced myopathic forms of Carnitine palmitoyltransferase II (CPT II) deficiency, a condition that affects how the body processes long-chain fatty acids for energy.
What each genotype means
Typical genetic profile
This is the most common genotype observed in the general population for this specific location in the CPT2 gene. It is considered the reference sequence, meaning it does not carry the specific variant associated with stress-induced myopathic CPT II deficiency. No specific clinical action is indicated by this result.
This is the most common genotype found across all major global populations.
Carrier of variant
You carry one copy of the variant associated with stress-induced myopathic CPT II deficiency. Because this condition is typically inherited in an autosomal recessive pattern, carrying a single copy is generally not expected to cause the clinical symptoms of the deficiency. You should consult with a genetic counselor if you have concerns about family history or reproductive planning.
This genotype is rare in the general population.
Increased risk profile
You carry two copies of this variant, which is associated with stress-induced myopathic CPT II deficiency. This condition can lead to muscle pain and myoglobinuria triggered by prolonged exercise, fasting, or cold exposure, as the body may struggle to metabolize fats for energy during these times. Please discuss these findings with your healthcare provider to determine if any clinical evaluation or lifestyle management is appropriate for your health.
This genotype is very rare in the general population.
What is the rs74315295 Variant?
The rs74315295 variant is a single nucleotide polymorphism (SNP) found within the CPT2 gene, which is located on chromosome 1. In genetics, a SNP represents a variation at a single position in the DNA sequence. This specific variant is cataloged in public databases as being associated with the myopathic form of CPT II deficiency. Because the CPT2 gene provides instructions for making an enzyme essential for mitochondrial function, variations in this gene can alter the enzyme's ability to perform its role. Researchers study these variants to understand how they contribute to metabolic health and the body's response to physical stress, such as prolonged exercise or fasting, which are known triggers for symptoms in individuals with CPT II deficiency.
The Role of the CPT2 Gene
The CPT2 gene encodes the carnitine palmitoyltransferase 2 enzyme, which is located in the inner mitochondrial membrane. This enzyme is a critical component of the carnitine shuttle system, which transports long-chain fatty acids into the mitochondria so they can be broken down and converted into energy. When the CPT2 gene contains pathogenic variants, the resulting enzyme may have reduced activity or stability. This impairment prevents the body from efficiently utilizing long-chain fats for fuel, particularly during periods of high energy demand or metabolic stress. Consequently, the body may struggle to maintain energy levels, leading to the accumulation of fatty acid intermediates that can be toxic to muscle tissue, manifesting as the clinical symptoms associated with CPT II deficiency.
Research and Clinical Associations
Scientific research has established that CPT II deficiency is an autosomal recessive disorder, meaning an individual typically needs to inherit two copies of a pathogenic variant to manifest the condition. The evidence linking specific CPT2 variants to clinical outcomes is generally considered moderate to strong, depending on the specific mutation. While some variants like p.Ser113Leu are well-documented in the literature as common causes of the adult-onset myopathic form, other variants like rs74315295 are studied for their specific contributions to stress-induced myopathy. It is important to note that the presence of a variant does not guarantee the development of severe symptoms, as clinical presentation can be influenced by other genetic factors, environmental triggers, and individual metabolic health. Research continues to refine our understanding of how these variants correlate with disease severity.
Population Frequency and Prevalence
The rs74315295 variant is classified as rare in the general population. Genetic variants associated with CPT II deficiency are generally uncommon, and their distribution can vary significantly across different ancestral groups. Because the condition is inherited in an autosomal recessive pattern, the prevalence of the disease itself is relatively low, though it may be underdiagnosed due to the mild nature of the myopathic form in some individuals. Large-scale genomic databases like gnomAD provide data on the frequency of such variants, helping researchers determine how often they appear in healthy populations versus those with diagnosed metabolic conditions. If you are concerned about your genetic risk, it is best to consult with a medical geneticist or a healthcare provider who can interpret these findings in the context of your personal and family health history.
Managing Genetic Information
Understanding your genetic profile can be informative, but it is not a substitute for professional medical advice. If you have identified that you carry a variant in the CPT2 gene, you cannot use this information to self-diagnose or determine your specific health risks without clinical context. Genetic testing results should always be reviewed by a qualified professional, such as a genetic counselor or physician, who can explain the implications of the findings. If you are taking medications or considering lifestyle changes based on genetic data, you must discuss these with your clinician or pharmacist. They can provide guidance on whether specific precautions, such as avoiding prolonged fasting or intense exercise, are necessary based on your unique genetic and clinical profile.
How common is this variant?
The rs74315295 variant is considered rare across most global populations, with specific genotype frequencies varying by ancestry.
Frequently asked questions
What is CPT II deficiency?
CPT II deficiency is an inherited metabolic disorder that prevents the body from using certain fats for energy. It can lead to symptoms like muscle pain and weakness, especially during exercise or fasting.
Is rs74315295 dangerous?
The risk associated with any genetic variant depends on many factors, including whether you have one or two copies and your overall health. You should discuss any findings with a healthcare provider to understand what they mean for you.
Can I prevent symptoms if I have this variant?
Management of CPT II deficiency often involves lifestyle adjustments, such as avoiding prolonged fasting and intense exercise. Always consult with a medical professional to create a plan tailored to your specific health needs.
Does this variant affect medication response?
Some genetic variants can influence how the body processes medications. If you are concerned about how your genetics might affect your treatment, please speak with your doctor or pharmacist.
Sources & further reading
Educational information only, last refreshed 9/25/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs74315295?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29